$FZMD
Fuse Medical, Inc.

2018 Q1 Form 10-Q Financial Statement

#000156459018013587 Filed on May 15, 2018

View on sec.gov

Income Statement

Concept 2018 Q1 2017 Q1 2016 Q4
Revenue $6.000M $148.2K $25.25M
YoY Change 3949.76% -23.21% 5160.42%
Cost Of Revenue $3.120M $48.31K $11.11M
YoY Change 6358.42% -40.57% 4730.43%
Gross Profit $2.880M $99.85K $14.13M
YoY Change 2784.38% -10.58% 5334.62%
Gross Profit Margin 48.0% 67.39% 55.96%
Selling, General & Admin $2.196M $914.4K $10.64M
YoY Change 140.15% 297.57% 4333.33%
% of Gross Profit 76.25% 915.8% 75.3%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $2.079K $5.347K $10.00K
YoY Change -61.12% 46.81% 0.0%
% of Gross Profit 0.07% 5.36% 0.07%
Operating Expenses $3.777M $3.066M $10.65M
YoY Change 23.21% 1211.26% 4337.5%
Operating Profit -$896.7K -$536.3K $3.480M
YoY Change 67.18% 339.12% 17300.0%
Interest Expense $35.91K $31.95K -$110.0K
YoY Change 12.39%
% of Operating Profit -3.16%
Other Income/Expense, Net $11.36K
YoY Change
Pretax Income -$943.4K -$525.0K $3.340M
YoY Change 79.7% 337.47% 33300.0%
Income Tax -$197.6K $0.00
% Of Pretax Income
Net Earnings -$735.0K -$525.0K $3.340M
YoY Change 40.0% 323.74% 33300.0%
Net Earnings / Revenue -12.25% -354.33% 13.23%
Basic Earnings Per Share -$0.03
Diluted Earnings Per Share -$25.74K -$55.32K $206.3K
COMMON SHARES
Basic Shares Outstanding 28.36M
Diluted Shares Outstanding

Balance Sheet

Concept 2018 Q1 2017 Q1 2016 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $800.0K $450.0K $780.0K
YoY Change 77.78% 400.0% 7700.0%
Cash & Equivalents $797.8K $666.5K $778.4K
Short-Term Investments
Other Short-Term Assets $30.00K $30.00K $20.00K
YoY Change 0.0% 50.0% 0.0%
Inventory $10.25M $21.63K $25.33K
Prepaid Expenses
Receivables $4.710M $122.7K $58.07K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $15.79M $619.1K $754.4K
YoY Change 2450.49% 157.96% 85.72%
LONG-TERM ASSETS
Property, Plant & Equipment $10.00K $6.467K $8.931K
YoY Change 54.63% -67.67% -64.24%
Goodwill $820.0K
YoY Change
Intangibles
YoY Change
Long-Term Investments $0.00 $0.00
YoY Change
Other Assets $580.0K
YoY Change
Total Long-Term Assets $1.420M $10.29K $18.82M
YoY Change 13701.15% -48.56% 65252.1%
TOTAL ASSETS
Total Short-Term Assets $15.79M $619.1K $754.4K
Total Long-Term Assets $1.420M $10.29K $18.82M
Total Assets $17.21M $629.4K $19.58M
YoY Change 2634.41% 142.07% 4400.13%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.530M $74.55K $2.453M
YoY Change 1952.23% -71.33% 892.37%
Accrued Expenses $2.190M $28.71K $5.097K
YoY Change 7526.94% 43.57% -58.45%
Deferred Revenue
YoY Change
Short-Term Debt $2.820M $150.0K $3.460M
YoY Change 1780.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $6.540M $294.7K $8.976M
YoY Change 2119.05% -22.44% 2619.7%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities $19.24M $0.00 $0.00
YoY Change
Total Long-Term Liabilities $19.24M $0.00 $0.00
YoY Change -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $6.540M $294.7K $8.976M
Total Long-Term Liabilities $19.24M $0.00 $0.00
Total Liabilities $25.79M $295.2K $316.5K
YoY Change 8637.07% -22.32% -26.4%
SHAREHOLDERS EQUITY
Retained Earnings -$3.017M -$2.901M
YoY Change 25.31%
Common Stock $3.352M $3.352M
YoY Change 44.47%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$8.578M $334.2K $10.60M
YoY Change
Total Liabilities & Shareholders Equity $17.21M $629.4K $767.1K
YoY Change 2634.41% 142.07% 76.35%

Cashflow Statement

Concept 2018 Q1 2017 Q1 2016 Q4
OPERATING ACTIVITIES
Net Income -$735.0K -$525.0K $3.340M
YoY Change 40.0% 323.74% 33300.0%
Depreciation, Depletion And Amortization $2.079K $5.347K $10.00K
YoY Change -61.12% 46.81% 0.0%
Cash From Operating Activities $734.7K $740.0K $2.840M
YoY Change -0.72% 825.0% -5780.0%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $20.33K $0.00
YoY Change -100.0% -100.0%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $660.0K
YoY Change
Cash From Investing Activities $0.00 -$20.00K $660.0K
YoY Change -100.0% -6700.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -741.6K -830.0K -3.030M
YoY Change -10.65%
NET CHANGE
Cash From Operating Activities 734.7K 740.0K 2.840M
Cash From Investing Activities 0.000 -20.00K 660.0K
Cash From Financing Activities -741.6K -830.0K -3.030M
Net Change In Cash -6.912K -110.0K 470.0K
YoY Change -93.72% -237.5% -883.33%
FREE CASH FLOW
Cash From Operating Activities $734.7K $740.0K $2.840M
Capital Expenditures $0.00 $20.33K $0.00
Free Cash Flow $734.7K $719.7K $2.840M
YoY Change 2.08% -7200.0%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
914408
CY2017Q1 fzmd Commissions
Commissions
2145656
CY2017Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-536324
CY2017Q1 us-gaap Interest Expense
InterestExpense
31946
CY2017Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
11362
CY2017Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-524962
CY2018Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-208392
CY2017Q1 us-gaap Net Income Loss
NetIncomeLoss
-524962
CY2017Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-307
CY2017Q1 us-gaap Depreciation
Depreciation
5347
CY2017Q1 us-gaap Operating Expenses
OperatingExpenses
3065718
CY2017Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
43308
CY2018Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-943359
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-734967
CY2018Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.03
CY2017Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.06
CY2018Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
28356561
CY2017Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
9399005
CY2018Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
79083
CY2018Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
59003
CY2018Q1 us-gaap Share Based Compensation
ShareBasedCompensation
138086
CY2018Q1 fzmd Provision For Bad Debts And Discounts
ProvisionForBadDebtsAndDiscounts
-247125
CY2017Q1 fzmd Provision For Bad Debts And Discounts
ProvisionForBadDebtsAndDiscounts
449707
CY2018Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-208392
CY2018Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2108429
CY2017Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1393823
CY2018Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-373509
CY2017Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-276565
CY2018Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1709
CY2017Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-57170
CY2018Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1053654
CY2017Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-478794
CY2018Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
354982
CY2017Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-285087
CY2018Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
734656
CY2017Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
736428
CY2017Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
20333
CY2017Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
300
CY2017Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-20033
CY2018Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
5240730
CY2017Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
4911930
CY2018Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
4499162
CY2017Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
4256760
CY2017Q1 us-gaap Payments Of Capital Distribution
PaymentsOfCapitalDistribution
173131
CY2018Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-741568
CY2017Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-828301
CY2018Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-6912
CY2017Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-111906
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
778447
CY2017Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
666541
CY2018Q1 us-gaap Interest Paid
InterestPaid
29698
CY2017Q1 us-gaap Interest Paid
InterestPaid
26457
CY2017Q1 fzmd Member Distributions Of Inventory
MemberDistributionsOfInventory
-20265
CY2018Q1 us-gaap Loss Contingency Lawsuit Filing Date
LossContingencyLawsuitFilingDate
January 27, 2014
CY2018Q1 us-gaap Loss Contingency Name Of Plaintiff
LossContingencyNameOfPlaintiff
M. Richard Cutler and Cutler Law Group, P.C.
CY2018Q1 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="text-align:justify;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of the condensed consolidated financial statements in accordance with GAAP, which requires the Company&#8217;s management to make estimates and assumptions that affect the Company&#8217;s reported amounts in the condensed consolidated financial statements.&nbsp;&nbsp;Actual results could differ from those estimates. Significant estimates on the accompanying condensed consolidated financial statements include the allowances for doubtful accounts and contractual pricing, valuation of inventories, accrued commissions, the fair value calculation of stock based compensation, and fair value calculation of contingent liabilities.</p></div>
CY2017 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2018Q1 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
10802
CY2017 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
40818
CY2017 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
40818
CY2018Q1 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-208392
CY2017 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0
CY2018Q1 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0
CY2017 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0
CY2017 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2018Q1 fzmd Income Tax Expense Benefit Net Of Current State Tax
IncomeTaxExpenseBenefitNetOfCurrentStateTax
-197590
CY2017 fzmd Income Tax Expense Benefit Net Of Current State Tax
IncomeTaxExpenseBenefitNetOfCurrentStateTax
40818
CY2016Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
150000
CY2018Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2512052
CY2017Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1304788
CY2018Q1 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2017Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2018Q1 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2018Q1 us-gaap Cash Uninsured Amount
CashUninsuredAmount
488115
CY2017Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
537388
CY2018Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2017 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2018Q1 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
0
CY2018Q1 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
0
CY2018Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2016Q4 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
64609
CY2016Q4 fzmd Proceeds From Issuance Of Common Stock Net Of Offering Costs
ProceedsFromIssuanceOfCommonStockNetOfOfferingCosts
655391
CY2018Q1 fzmd Percentage Of Common Stock Issued
PercentageOfCommonStockIssued
0.614
CY2018Q1 fzmd Percentage Of Common Stock Outstanding
PercentageOfCommonStockOutstanding
0.614
CY2016Q4 us-gaap Goodwill
Goodwill
820000
CY2017Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
26960
CY2018Q1 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
10802
CY2017Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
10065
CY2018Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
268838
CY2018Q1 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
40342
CY2018Q1 fzmd Deferred Tax Assets Accounts Receivable
DeferredTaxAssetsAccountsReceivable
107524
CY2018Q1 fzmd Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Remaining Contractual Term Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted
P9Y10M24D
CY2018Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y6M
CY2018Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y1M6D
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1717000
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1067000
CY2018Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
1067000
CY2018Q1 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2018Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
93002
CY2018Q1 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
76677
CY2018Q1 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
586383
CY2018Q1 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
0
CY2018Q1 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
2713
CY2018Q1 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
2713
CY2018Q1 fzmd Deferred Tax Assets Liabilities Net Before Valuation Allowance
DeferredTaxAssetsLiabilitiesNetBeforeValuationAllowance
583670
CY2017Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
0
CY2018Q1 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
0
CY2018Q1 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
583670
CY2018Q1 us-gaap Loss Contingency Name Of Defendant
LossContingencyNameOfDefendant
Fuse, Alan Meeker, Rusty Shelton, Jonathan Brown, Robert H. Donehew and GolfRounds.com, Inc.
CY2018Q1 us-gaap Loss Contingency Date Of Dismissal
LossContingencyDateOfDismissal
2014-04-21
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1302052
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1210000
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2512052
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1312052
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.20
CY2018Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.21
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.86
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.20
CY2017Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
172704
CY2017Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
40342
CY2017Q4 fzmd Deferred Tax Assets Accounts Receivable
DeferredTaxAssetsAccountsReceivable
81927
CY2017Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
57458
CY2017Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
25792
CY2017Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
378223
CY2017Q4 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
0
CY2017Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
2945
CY2017Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
2945
CY2017Q4 fzmd Deferred Tax Assets Liabilities Net Before Valuation Allowance
DeferredTaxAssetsLiabilitiesNetBeforeValuationAllowance
375278
CY2016Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
308026
CY2017 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-308026
CY2017Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
375278
CY2017 fzmd Increase Decrease In Deferred Tax Asset
IncreaseDecreaseInDeferredTaxAsset
208392
CY2018Q1 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
1280179
CY2018Q1 fzmd Net Operating Loss Carryforwards Earliest Expiration Year
NetOperatingLossCarryforwardsEarliestExpirationYear
2019
CY2018Q1 fzmd Net Operating Loss Carryforwards Latest Expiration Year
NetOperatingLossCarryforwardsLatestExpirationYear
2038
CY2018Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2017Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.350
CY2018Q1 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.011
CY2017Q1 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.058
CY2018Q1 fzmd Effective Income Tax Rate Reconciliation Permanent Differences
EffectiveIncomeTaxRateReconciliationPermanentDifferences
-0.006
CY2017Q1 fzmd Effective Income Tax Rate Reconciliation Permanent Differences
EffectiveIncomeTaxRateReconciliationPermanentDifferences
-0.555
CY2018Q1 us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
0.000
CY2017Q1 us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
0.205
CY2018Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.193
CY2017Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.058
CY2018Q1 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
259000
CY2017Q1 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
216000

Files In Submission

Name View Source Status
0001564590-18-013587-index-headers.html Edgar Link pending
0001564590-18-013587-index.html Edgar Link pending
0001564590-18-013587.txt Edgar Link pending
0001564590-18-013587-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
fzmd-10q_20180331.htm Edgar Link pending
fzmd-20180331.xml Edgar Link completed
fzmd-20180331.xsd Edgar Link pending
fzmd-20180331_cal.xml Edgar Link unprocessable
fzmd-20180331_def.xml Edgar Link unprocessable
fzmd-20180331_lab.xml Edgar Link unprocessable
fzmd-20180331_pre.xml Edgar Link unprocessable
fzmd-ex311_8.htm Edgar Link pending
fzmd-ex312_7.htm Edgar Link pending
fzmd-ex321_6.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending